Currently, Rein Therapeutics Inc [RNTX] is trading at $1.54, up 5.48%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RNTX shares have gain 22.22% over the last week, with a monthly amount glided 16.67%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Rein Therapeutics Inc [NASDAQ: RNTX] stock has seen the most recent analyst activity on September 22, 2025, when H.C. Wainwright initiated its Buy rating and assigned the stock a price target of $10. Previously, Rodman & Renshaw started tracking the stock with Buy rating on January 28, 2025, and set its price target to $8. On July 24, 2017, William Blair initiated with a Outperform rating. Jefferies started tracking the stock assigning a Buy rating and suggested a price target of $20 on July 24, 2017. BofA/Merrill initiated its recommendation with a Buy and recommended $19 as its price target on July 24, 2017.
This stock has fluctuated between a low of $1.04 and a high of $3.50 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Rein Therapeutics Inc [NASDAQ: RNTX] shares were valued at $1.54 at the most recent close of the market. An investor can expect a potential return of 289.61% based on the average RNTX price forecast.
Analyzing the RNTX fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -1.1, Equity is -2.17 and Total Capital is -1.27.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.4733 points at the first support level, and at 1.4067 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.5833, and for the 2nd resistance point, it is at 1.6267.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Rein Therapeutics Inc [NASDAQ:RNTX] is 0.90. In addition, the Quick Ratio stands at 0.90 and the Cash Ratio stands at 0.7.
Transactions by insiders
Recent insider trading involved Voss Capital, LP, 10% Owner, that happened on Nov 14 ’25 when 0.1 million shares were purchased. 10% Owner, Voss Capital, LP completed a deal on Oct 28 ’25 to buy 0.18 million shares. Meanwhile, 10% Owner Voss Capital, LP bought 97482.0 shares on Oct 27 ’25.
